Detection and quantification of virus DNA in plasma of patients with Epstein-Barr virus-associated diseases
- 1 July 1995
- journal article
- clinical trial
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 33 (7) , 1765-8
- https://doi.org/10.1128/jcm.33.7.1765-1768.1995
Abstract
Epstein-Barr virus (EBV) causes various diseases, such as infectious mononucleosis (IM), fatal IM, EBV-associated hemophagocytic syndrome (EBVAHS), and chronic active EBV infection (CAEBV). In the present study, cell-free EBV DNA was detected in the plasma of patients with EBV-associated diseases by PCR assay. The patients included 20 patients with IM, 2 patients with fatal IM, 4 patients with EBVAHS, 4 patients with CAEBV, and 38 healthy children (20 EBV seropositive and 18 EBV seronegative). In patients with IM, plasma samples were positive for EBV DNA in all patients (100%) in the acute phase and in 44% of the patients in the convalescent phase, but plasma samples from the 38 healthy control children were negative (0%) for EBV DNA. Quantitative PCR assay revealed that plasma from patients with IM contained the highest amount of virus DNA within 7 days following the onset of disease (mean, 6 x 10(4) copies per ml). The EBV DNA concentration decreased thereafter as the patients recovered. Plasma from patients with fatal IM contained more than 100 times more copies of EBV DNA (3 x 10(7) copies per ml) than plasma from patients with IM. Plasma from patients with the acute phase of EBVAHS contained 10 times more copies of EBV DNA (5 x 10(5) copies per ml) than plasma from IM, and then patients with the number of copies decreased similarly in both groups of patients in the convalescent phase (2 x 10(4) copies per ml). The amount of virus DNA in patients with CAEBV (6 x 10(4) copies per ml) was similar to that noted in patients with IM; however, it became higher (1 x 10(6) copies per ml) when the patients' clinical status deteriorated. These data suggest that the presence of cell-free EBV DNA in plasma is a common phenomenon in patients with EBV-associated diseases. The concentration of EBV DNA in plasma seems to be higher in patients with the more severe clinical categories of EBV diseases.Keywords
This publication has 25 references indexed in Scilit:
- T‐cell receptor Vα region usage in the cerebrospinal fluid of patients with mumps meningitisJournal of Medical Virology, 1993
- Quantitative analysis of herpes simplex virus DNA in cerebrospinal fluid of children with herpes simplex encephalitisJournal of Medical Virology, 1993
- Increased sensitivity for detection of human cytomegalovirus in urine by removal of inhibitors for the polymerase chain reactionJournal of Virological Methods, 1992
- Zidovudine-Interferon- Combination Therapy in Patients with Advanced Human Immunodeficiency Virus Type 1 Infection: Biphasic Response of p24 Antigen and Quantitative Polymerase Chain ReactionThe Journal of Infectious Diseases, 1992
- Direct measurement of viraemia in patients infected with HIV-1 and its relationship to disease progression and zidovudine therapyJournal of Medical Virology, 1991
- Effect of α‐interferon therapy on hepatitis C viraemia in community‐acquired chronic non‐A, non‐B hepatitis: A quantitative polymerase chain reaction studyJournal of Medical Virology, 1991
- Detection by PCR of HHV-6 and EBV DNA in blood and oropharynx of healthy adults and HIV-seropositivesThe Lancet, 1990
- Avoiding false positives with PCRNature, 1989
- Leukocyte Response in Childhood Infectious MononucleosisAmerican Journal of Diseases of Children, 1981
- Quantitative Evaluation of Epstein-Barr-Virus-Infected Mononuclear Peripheral Blood Leukocytes in Infectious MononucleosisNew England Journal of Medicine, 1977